PAN-01-102 - Multicenter Phase I/II Study to Evaluate Safety and Tolerability of Pan-90806 Eye Drops Suspension in Treatment-Naive Participants with Neovascular Age-Related Macular Degeneration (AMD)
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
PanOptica
Start Date
April 4, 2018
End Date
April 2, 2020
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
PanOptica
Start Date
April 4, 2018
End Date
April 2, 2020